Acadia Pharmaceuticals | ACAD - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cara Therapeutics USD 19.85M 883K 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Cytokinetics USD 129.84M 7.32M 2026-03
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Incyte USD 3.98B 33.45M 2026-06
J&J USD 20.42B 1.27B 2026-06
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Pfizer USD 976M 727M 2026-06
Prothena USD 329.46M 21.93M 2026-03
PTC Therapeutics USD 1.05B 215.9M 2026-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06